According to the American companies which are engaged in implementation of reproductive technologies, the Chinese market of such services is huge and unsatisfied. Dr. Kevin Dudi, the chairman of society of auxiliary reproductive technologies (SART) told about it on recent reception of the Chinese Association of doctors (CMDA) and World organization of reproduction and genetics (GFG). According to the research of Americans, infertility in China will reach 40 million by 2020.
According to Mr. Dudi, the Chinese doctors already adopted a part of the American technologies. In search of the best method specialists of two countries decided to unite reproductive technologies of the western society and traditional Chinese medicine. SART signed the relevant contract with the Shanghai University of Traditional Chinese Medicine.
Now the American company INVO Bioscience tries to obtain the exclusive agreement for a period of three years. The essence of the agreement is that at the first stage the USA scientists brings the tools and gets access to clinical data of patients free of charge. Then they start pedagogical activity, training doctors and embryologists in the city of Hainan.